External quality assurance scheme for Bordetella identification and B. pertussis typing 2013
This report presents the results of the first external quality assurance (EQA) scheme for Bordetella identification and typing funded by the European Centre for Disease Prevention and Control (ECDC).
External quality assurance scheme for Bordetella pertussis serology 2013
This report presents the results of an external quality assurance (EQA) scheme for Bordetella pertussis serology which was carried out during the summer of 2013.
OECD report: Health at a Glance Europe 2018 - Public health laboratory capacity to control infectious diseases threats
This OECD report “Health at a Glance Europe-2018” includes a summary of the EULabCap indicator results indicating EU progress in the chapter on health systems resilience.
European external quality assessment programme for influenza virus 2018
Influenza epidemics occur every winter with high impact on disease burden, hospitalisations and excess mortality in countries in the WHO European Region. To understand the characteristics of circulating influenza viruses during seasonal epidemics, virological influenza surveillance is performed and detected viruses are further characterised at national influenza centres (NICs) that are part of the wider network of the WHO Global Influenza Surveillance and Response System (GISRS). External quality assessments (EQAs) are important instruments in assessing the quality of the generated data that are reported nationally and internationally through The European Surveillance System (TESSy).
Fifth external quality assessment scheme for Salmonella typing
This report presents the results of the fifth round of the Salmonella External Quality Assessment (EQA) scheme for typing of Salmonella enterica spp. enterica (further EQA-5).
External quality assessment scheme for influenza antiviral susceptibility for the European Reference Laboratory Network for Human Influenza – 2015
In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This report presents the results of the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008.